Polycythemia vera: the blood that runs too thick
Last updated September 3, 2026.
Polycythemia vera (PV) is the slow-growing blood disorder (the myeloproliferative neoplasm: the bone marrow making too many red blood cells, often the white cells and the platelets too): the blood thickening, which drives the clot risk (the main danger) and the odd symptoms (the itching after the warm showers, the burning-red hands-and-feet, the headaches, the fullness from the enlarged spleen). It carries the JAK2 mutation in the nearly-all cases, the treatment is the satisfyingly-direct kind (the venesection: the blood-letting: plus the low-dose aspirin, plus the count-lowering medicines for the higher-risk), and the managed-kind rows run the near-normal lifespans.
What does it feel like?
Often the routine-blood-test find. The symptoms: the aquagenic itching (the after-the-warm-shower itching: the distinctive-kind clue), the burning-red hands-or-feet (the erythromelalgia), the headaches and the dizziness, the blurred vision, the facial redness (the plethoric-kind), the gout, the left-upper-belly fullness (the spleen), and the clot-kind events (the strokes, the vein clots: sometimes the presenting kind). The bleeding-paradox kind (the bruising, the nosebleeds) appears in the some.
Why does it happen?
The JAK2 mutation (the acquired kind: the red-cell production permanently switched-on: the random-event row, not the inherited, not the lifestyle), the marrow over-producing, and the hematocrit climbing (the thickness the treatment targets). The diagnosis needs the excluding of the secondary kinds (the smoking, the sleep-apnea, the dehydration, the testosterone, the altitude: the common reversible rows) before the PV label lands.
How is it treated?
- The venesection: the blood drawn (the unit-at-a-time: the hematocrit kept under the 45-percent kind: the surprisingly-effective direct treatment, the frequency easing to the maintenance).
- The low-dose aspirin: the clot-risk lowered for the all (the microvascular symptoms often easing on it).
- The cytoreduction for the higher-risk: the hydroxyurea-kind (the over-60s or the clot-history rows), the interferon, the ruxolitinib for the resistant-kind rows.
- The risks closed out: the smoking stopped, the pressure-and-cholesterol managed (the clot-risk compounding), and the monitoring lifelong (the small long-term transformation risk: the watched row).
When is it urgent?
The 911-or-ER for the clot-kind symptoms (the stroke signs, the chest pain, the breathlessness, the one-leg swelling), and the prompt review for the new severe headaches, the vision changes, or the unusual bleeding. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Is taking blood out really a real treatment?
The evidence-based kind: the venesection removes the red-cell surplus directly (the hematocrit target under the 45-percent kind: the randomized-trial row showed the hard outcomes improving: the fewer strokes-and-clots), with the no-drug-toxicity attached (the iron-lowering side-effect is even useful in the PV), and the frequency easing over the time (the induction-kind weekly, then the maintenance every-few-months kind). The old treatment, yes: the discredited-with-age, no: the hematology guidelines keep it first-line because the trials say so.
Is PV a cancer? What is my life expectancy?
The classification-honest row: it sits in the blood-cancer family (the myeloproliferative neoplasm), and the behavior row is what matters: the slow, the non-spreading, the managed-for-decades kind (the near-normal life expectancy for the well-controlled rows: the clots being the main danger, which is what the venesection-aspirin row prevents). The long-term transformation risk exists (the myelofibrosis, the small leukemia-kind percentages over the decades), which is what the monitoring rhythm is for: the watched row, not the looming one.
Why does my skin itch after hot showers?
The aquagenic pruritus, the PV's most distinctive clue (the mast-cells in the skin reacting as the warm water shifts the blood-flow: the minutes-of-itching row, the no-rash kind), and the practical rows: the cooler-shorter showers, the patting-not-rubbing, the aspirin row sometimes helping (the platelet-kind itch), and the counts-settling easing it over the time. The new-antihistamine rows get trialed for the stubborn kind: worth the mentioning at the visits.
What are my actual clot risks, and what prevents them?
The two-sided row: the thick blood clots more (the strokes, the heart-attacks, the vein-clots: the PV's main danger), and the prevention is the proven row (the hematocrit kept under the target by the venesection, the low-dose aspirin daily for the all, the cytoreduction added for the higher-risk rows), with the compounding-kind risks worth the closing (the smoking: the multiply-kind, the blood pressure, the cholesterol, the immobility-kind rows). The managed PV's clot risk drops toward the ordinary: the treatment working is the measurable kind here.
Could the high hemoglobin have been something simpler?
The hematologist's first question too: the secondary rows (the smoking, the sleep-apnea: the common kind, the dehydration, the testosterone-supplements, the altitude, the lung-disease rows) all raise the red cells, and the PV diagnosis requires the excluding-them (the JAK2-testing settling most rows: the positive-kind = the PV-row, the negative-kind hunting the secondary), so your positive JAK2 is the diagnostic-solidity row: the PV it is, and the secondary-hunt was already walked.
Can I exercise, fly, live normally?
The yes-with-the-sense row: the exercise encouraged (the hydrated kind: the dehydration thickens the blood further: the water-bottle habit), the flying fine (the hydration-plus-moving row, the compression-stockings for the long-kind), the normal-life row real (the work, the travel, the row-continuing), and the procedure-kind caution (the surgeries-and-dental-rows: the team told: the clot-and-bleed rows managed around the procedures). The diagnosis changes the checklist, not the life-plan.